Back

Structural remodeling and left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Structural and electrical remodelling in atrial fibrillation Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Ekaterina Zaslavskaya

Saint-Petersburg State Medical University named I.P.Pavlov, Saint Petersburg (Russian Federation)

7 More presentations in this session

Presentation thumbnail
Atrial cardiomyopathy: cardiac-bone marrow networking dysfunction via folate-resistance
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides Video
Presentation thumbnail
Bi-atrial and atrial appendages remodeling in patients with atrial fibrillation and spontaneous cardioversion
Doctor L. Soulat-Dufour (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Stimulated periodic repolarisation dynamics as a predictor of new-onset device-detected atrial fibrillation
Doctor P. Spitaler (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Evaluation of atrial substrate using COHERENT mapping in atrial fibrillation: correlation with clinical profiles and structural remodeling
Doctor C. Kitamura (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Emergence of sex differences on the risk of left atrial fibrosis in atrial fibrillation - a REAL-AF study
Mr A. Nguyen (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Structural and electrical remodelling in atrial fibrillation

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
The impact of obesity on the left atrium and arrhythmia recurrence in patients with atrial fibrillation undergoing ablation.
thumbnail
Congress Presentation
Impact of adjacent thoracic structures in negative left atrial remodelling in atrial fibrillation
thumbnail
Congress Presentation
Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources